TFS
ATYR

Thoroughbred Financial Services’s aTyr Pharma ATYR Stock Holding History

Thoroughbred Financial Services’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-210,775
Closed -$1.07M – 590
2025
Q2 		$1.07M Buy
+210,775
New +$829K 0.07% 257

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Thoroughbred Financial Services's ATYR Position: Q3 2025 in Review

Thoroughbred Financial Services sold out of aTyr Pharma (ATYR) in Q3 2025, closing a stake of 210,775 shares — an estimated $1.07M sold.

Thoroughbred Financial Services first reported a position in ATYR in Q2 2025 and held it in 1 quarter. The position peaked at $1.07M in Q2 2025. 103 funds tracked by Wall St. Rank hold ATYR as of Q3 2025.

  • Thoroughbred Financial Services reported no remaining aTyr Pharma position as of Q3 2025 after selling out during the quarter.
  • Thoroughbred Financial Services sold 210,775 aTyr Pharma shares in Q3 2025, an estimated $1.07M.
  • Thoroughbred Financial Services first reported a position in aTyr Pharma in Q2 2025 and held it in 1 quarter.
  • Thoroughbred Financial Services's aTyr Pharma position peaked at $1.07M in Q2 2025.
  • 103 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2025.

Based on Thoroughbred Financial Services's 13F filing for Q3 2025, filed 10 Nov 2025.